Market News AIOpen the app

VSTM stock news · Verastem, Inc.

Stories about Verastem, Inc. (VSTM) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for VSTM

Follow Verastem, Inc. (VSTM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VSTM
Free on the App Store and Google Play, or on the web.
  1. Nov 19, 2026, 4:54 PM ET · New boss

    Verastem announced that CEO Daniel W. Paterson is retiring and Michael Bailey will take over on January 1, 2027.

    Neutral

    Verastem filed details of Michael Bailey's CEO appointment for January 1, 2027, and a $40,000 monthly fee for transition advice. The filing does not change the business outlook.

  2. Oct 14, 2026, 5:24 PM ET · Market

    Verastem, Inc.: Other Events (VSTM)

    Neutral

    Verastem expects to receive about $234.7 million after costs from selling shares and warrants. The cash helps fund the company, but the new shares spread ownership more thinly, leaving the outlook unchanged in this filing.

  3. Oct 14, 2026, 6:16 AM ET · Market

    Verastem, Inc. shares how they did financially and their business situation.

    Good for VSTM

    Verastem estimated that quarterly product sales more than doubled and cash grew from a year earlier. Those figures support a brighter outlook despite an upcoming CEO handover.

  4. Oct 12, 2026, 9:09 AM ET · Results

    Verastem Oncology shares details from its earnings call for the second quarter of 2026.

    Good for VSTM

    Verastem reported a sales rebound, new cash and progress in cancer studies. These updates support a more favorable outlook, though its funding and self-funding plans are not fully complete.